Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, representing a minor update to the site. No user-facing content changes are indicated in the provided context.
    Difference
    0.0%
    Check dated 2026-07-03T21:45:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    - Revision label updated from v3.6.0 to v3.6.2, indicating a new page build. The change does not modify study content or data displayed on the page.
    Difference
    0.0%
    Check dated 2026-06-26T23:57:18.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label was updated from 'Intervention / Treatment' to 'Intervention/Treatment'. Recruitment status was updated to 'No longer looking for participants' and the site revision footer changed from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T14:19:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a minor backend or UI update. No changes were made to the displayed study details or related content.
    Difference
    0.0%
    Check dated 2026-06-05T11:30:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision v3.5.4 was added to the study's record, replacing the previous v3.5.3. This signals a new version of the page, likely reflecting minor updates to the study record or its metadata rather than a substantive change to study content.
    Difference
    0.0%
    Check dated 2026-05-15T04:46:49.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag updated to v3.5.3, replacing the previous v3.5.2. This indicates an update to the page version rather than changes to the study data or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T17:42:26.000Z thumbnail image

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.